Home > Insider Trading > Filing (0001209191-16-137392)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
938296	H Theodore Stanley	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-16	15,000	$5.96	17,000	No	4	M	Direct
Common Stock	Disposition	2016-08-16	15,000	$18.02	2,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2016-08-16	15,000	$0.00	15,000	$5.96

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,000		2023-08-12	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	6,000	Indirect	by non-profit corporation
Common Stock	10,200	Indirect	by limited partnership

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.95 to $18.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The Reporting Person disclaims beneficial ownership of the Securities except to the extent of his pecuriniary interest therein.
The exercise price reflects a 3-for-2 forward stock split effected by the Issuer on March 28, 2014 and a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
One third of the shares subject to the option vested on August 12, 2014 and the remainder vested in 24 equal monthly installments thereafter until fully vested and exercisable on August 12, 2016.
On March 27, 2014 and June 5, 2015 the Issuer effected a 3-for-2 forward stock split and a 2-for-1 forward stock split, respectively, both pursuant to a stock dividend, resulting in the reporting person's ownership of an aggregate of 15,000 additional options.